PT  - JOURNAL ARTICLE
AU  - Karthikeyan, Smruthi
AU  - Levy, Joshua I
AU  - De Hoff, Peter
AU  - Humphrey, Greg
AU  - Birmingham, Amanda
AU  - Jepsen, Kristen
AU  - Farmer, Sawyer
AU  - Tubb, Helena M.
AU  - Valles, Tommy
AU  - Tribelhorn, Caitlin E
AU  - Tsai, Rebecca
AU  - Aigner, Stefan
AU  - Sathe, Shashank
AU  - Moshiri, Niema
AU  - Henson, Benjamin
AU  - Mark, Adam M.
AU  - Hakim, Abbas
AU  - Baer, Nathan A
AU  - Barber, Tom
AU  - Belda-Ferre, Pedro
AU  - Chacón, Marisol
AU  - Cheung, Willi
AU  - Cresini, Evelyn S
AU  - Eisner, Emily R
AU  - Lastrella, Alma L
AU  - Lawrence, Elijah S
AU  - Marotz, Clarisse A
AU  - Ngo, Toan T
AU  - Ostrander, Tyler
AU  - Plascencia, Ashley
AU  - Salido, Rodolfo A
AU  - Seaver, Phoebe
AU  - Smoot, Elizabeth W
AU  - McDonald, Daniel
AU  - Neuhard, Robert M
AU  - Scioscia, Angela L
AU  - Satterlund, Alysson M.
AU  - Simmons, Elizabeth H
AU  - Abelman, Dismas B.
AU  - Brenner, David
AU  - Bruner, Judith C.
AU  - Buckley, Anne
AU  - Ellison, Michael
AU  - Gattas, Jeffrey
AU  - Gonias, Steven L.
AU  - Hale, Matt
AU  - Hawkins, Faith
AU  - Ikeda, Lydia
AU  - Jhaveri, Hemlata
AU  - Johnson, Ted
AU  - Kellen, Vince
AU  - Kremer, Brendan
AU  - Matthews, Gary
AU  - McLawhon, Ronald W.
AU  - Ouillet, Pierre
AU  - Park, Daniel
AU  - Pradenas, Allorah
AU  - Reed, Sharon
AU  - Riggs, Lindsay
AU  - Sanders, Alison
AU  - Sollenberger, Bradley
AU  - Song, Angela
AU  - White, Benjamin
AU  - Winbush, Terri
AU  - Aceves, Christine M
AU  - Anderson, Catelyn
AU  - Gangavarapu, Karthik
AU  - Hufbauer, Emory
AU  - Kurzban, Ezra
AU  - Lee, Justin
AU  - Matteson, Nathaniel L
AU  - Parker, Edyth
AU  - Perkins, Sarah A
AU  - Ramesh, Karthik S
AU  - Robles-Sikisaka, Refugio
AU  - Schwab, Madison A
AU  - Spencer, Emily
AU  - Wohl, Shirlee
AU  - Nicholson, Laura
AU  - Mchardy, Ian H
AU  - Dimmock, David P
AU  - Hobbs, Charlotte A
AU  - Bakhtar, Omid
AU  - Harding, Aaron
AU  - Mendoza, Art
AU  - Bolze, Alexandre
AU  - Becker, David
AU  - Cirulli, Elizabeth T
AU  - Isaksson, Magnus
AU  - Schiabor Barrett, Kelly M
AU  - Washington, Nicole L
AU  - Malone, John D
AU  - Schafer, Ashleigh Murphy
AU  - Gurfield, Nikos
AU  - Stous, Sarah
AU  - Fielding-Miller, Rebecca
AU  - Garfein, Richard S.
AU  - Gaines, Tommi
AU  - Anderson, Cheryl
AU  - Martin, Natasha K.
AU  - Schooley, Robert
AU  - Austin, Brett
AU  - MacCannell, Duncan R.
AU  - Kingsmore, Stephen F
AU  - Lee, William
AU  - Shah, Seema
AU  - McDonald, Eric
AU  - Yu, Alexander T.
AU  - Zeller, Mark
AU  - Fisch, Kathleen M
AU  - Longhurst, Christopher
AU  - Maysent, Patty
AU  - Pride, David
AU  - Khosla, Pradeep K.
AU  - Laurent, Louise C.
AU  - Yeo, Gene W
AU  - Andersen, Kristian G
AU  - Knight, Rob
TI  - Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission
AID  - 10.1101/2021.12.21.21268143
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2021.12.21.21268143
4099  - http://medrxiv.org/content/early/2022/04/04/2021.12.21.21268143.short
4100  - http://medrxiv.org/content/early/2022/04/04/2021.12.21.21268143.full
AB  - As SARS-CoV-2 continues to spread and evolve, detecting emerging variants early is critical for public health interventions. Inferring lineage prevalence by clinical testing is infeasible at scale, especially in areas with limited resources, participation, or testing/sequencing capacity, which can also introduce biases. SARS-CoV-2 RNA concentration in wastewater successfully tracks regional infection dynamics and provides less biased abundance estimates than clinical testing. Tracking virus genomic sequences in wastewater would improve community prevalence estimates and detect emerging variants. However, two factors limit wastewater-based genomic surveillance: low-quality sequence data and inability to estimate relative lineage abundance in mixed samples. Here, we resolve these critical issues to perform a high-resolution, 295-day wastewater and clinical sequencing effort, in the controlled environment of a large university campus and the broader context of the surrounding county. We develop and deploy improved virus concentration protocols and deconvolution software that fully resolve multiple virus strains from wastewater. We detect emerging variants of concern up to 14 days earlier in wastewater samples, and identify multiple instances of virus spread not captured by clinical genomic surveillance. Our study provides a scalable solution for wastewater genomic surveillance that allows early detection of SARS-CoV-2 variants and identification of cryptic transmission.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.protocols.io/view/high-throughput-wastewater-sars-cov-2-detection-pi-bshvnb66 Funding StatementThis work has been funded by CDC BAA contracts 75D30121P10258 (Helix) and 75D30120C09795 (G.W.Y., R.K., L.C.L., and K.G.A.), NIH NIAID 3U19AI135995-03S2 (K.G.A.), U19AI135995 (K.G.A.), U01AI151812 (K.G.A.), NIH NCATS UL1TR002550 (K.G.A.), the Conrad Prebys Foundation (K.G.A.), NIH 5T32AI007244-38 (J.I.L.), NIH Pioneer Grant 1DP1AT010885 (R.K), NSF RAPID 2029069 (R.K.), San Diego County Health and Human Services Agency (R.F.M), NIH S10OD026929 (K.J.). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of California San Diego Institutional Review Boards (IRB) provided human subject protection oversight of the of the data obtained by the EXCITE lab for the campus clinical samples (IRB approval #210699, #200477). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and any sample identifiers included were de-identified. The wastewater component of this project was discussed with our Institutional Review Board, and was not deemed to be human subject research, as it did not record personally identifiable information.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability and relevant links provided in the manuscript https://searchcovid.info/dashboards/wastewater-surveillance/